An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: Expression of stem cell factor by lesional mast cells

American Journal of Clinical Pathology

Volumn 118, Issue 2, 2002, Pages 242-247

  Akin, Cem ^a   Jaffe, Elaine S ^b   Raffeld, Mark ^b   Kirshenbaum, Arnold S ^a   Daley, Trisha ^a   Noel, Pierre ^c   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

B lymphocytes; Benign lymphoid aggregates; Bone marrow; Mast cells; Mastocytosis; Stem cell factor; T lymphocytes

Indexed keywords

CYTOKINE; STEM CELL FACTOR;

ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; BONE MARROW BIOPSY; BONE MARROW DISEASE; CELL AGGREGATION; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID CELL; MAST CELL; MASTOCYTOSIS; PARACRINE SIGNALING; PRIORITY JOURNAL; T LYMPHOCYTE; ADULT; BIOPSY; BIOSYNTHESIS; BONE MARROW; CHEMISTRY; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; B-LYMPHOCYTES; BIOPSY; BONE MARROW; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MASTOCYTOSIS; MIDDLE AGED; STEM CELL FACTOR; T-LYMPHOCYTES;

EID: 0036676898     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/71KH-4JE4-E0J1-7THH     Document Type: Article

References (38)

1. Parker RI. Hematologic aspects of mastocytosis, I: bone marrow pathology in adult and pediatric systemic mast cell disease. J Invest Dermatol. 1991;96:47S-51S.
2. Webb TA, Li CY, Yam LT. Systemic mast cell disease: a clinical and hematopathologic study of 26 cases. Cancer. 1982;49:927-938.
3. Brunning RD, McKenna RW, Rosai J, et al. Systemic mastocytosis: extracutaneous manifestations. Am J Surg Pathol. 1983;7:425-438.
4. Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol. 1985;16:808-814.
5. Ridell B, Olafsson JH, Roupe G, et al. The bone marrow in urticaria pigmentosa and systemic mastocytosis: cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid. Arch Dermatol. 1986;122:422-427.
6. Travis WD, Li CY, Bergstralh EJ, et al. Systemic mast cell disease: analysis of 58 cases and literature review [published correction appears in Medicine (Baltimore). 1990;69:34]. Medicine (Baltimore). 1988;67:345-368.
7. Homy HP, Kaiserling E. Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study. Br J Haematol. 1988;69:449-455.
8. Horny HP, Engst U, Walz RS, et al. In situ immunophenotyping of lymphocytes in human bone marrow: an immunohistochemical study. Br J Haematol. 1989;71:313-321.
9. Galli SJ, Tsai M, Wershil BK, et al. Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int Arch Allergy Immunol. 1995;107:51-53.
10. Kirshenbaum AS, Goff JP, Kessler SW, et al. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol. 1992;148:772-777.
11. Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell. 1990;63:213-224.
12. Nagata H, Worobec AS, Oh CK, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A. 1995;92:10560-10564.
13. Longley BJ Jr, Metcalfe DD, Tharp M, et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A. 1999;96:1609-1614.
14. Valent P, Horny H, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603-625.
15. Horny HP, Sillaber C, Menke D, et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol. 1998;22:1132-1140.
16. Morimoto M, Tsujimura T, Kanakura Y, et al. Expression of c-kit and stem cell factor mRNA in liver specimens from healthy adult dogs. Am J Vet Res. 1998;59:363-366.
17. Lemoli RM, Fortuna A, Grande A, et al. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells. Br J Haematol. 1994;88:760-769.
18. Yamaguchi H, Ishii E, Saito S, et al. Umbilical vein endothelial cells are an important source of c-kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells. Br J Hoematol. 1996;94:606-611.
19. Finotto S, Mekori YA, Metcalfe DD. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J Clin Invest. 1997;99:1721-1728.
20. Longley BJ Jr, Morganroth GS, Tyrrell L, et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med. 1993;328:1302-1307.
21. Castells MC, Friend DS, Bunnell CA, et al. The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosis. J Allergy Clin Immunol. 1996;98:831-840.
22. Zhang S, Anderson DF, Bradding P, et al. Human mast cells express stem cell factor. J Pathol 1998;186:59-66.
23. de Paulis A, Minopoli G, Arbustini E, et al. Stem cell factor is localized in, released from, and cleaved by human mast cells. J Immunol. 1999;163:2799-2808.
24. Ashman LK, Cambareri AC, To LB, et al. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood. 1991;78:30-37.
25. Billips LG, Petitte D, Dorshkind K, et al. Differential roles of stromal cells, interleukin-7, and kit-ligand in the regulation of B lymphopoiesis. Blood. 1992;79:1185-1192.
26. Matsuzaki Y, Gyotoku J, Ogawa M, et al. Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation. J Exp Med. 1993;178:1283-1292.
27. Funk PE, Varas A, Witte PL. Activity of stem cell factor and IL-7 in combination on normal bone marrow B lineage cells. J Immunol. 1993;150:748-752.
28. Godfrey DI, Zlotnik A, Suda T. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol. 1992;149:2281-2285.
29. Akin C, Kirshenbaum AS, Semere T, et al. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp Hematol. 2000;28:140-147.
30. Taylor ML, Dastych J, Sehgal D, et al. The Kit-activating mutation D816V enhances stem cell factor: dependent chemotaxis. Blood. 2001;98:1195-1199.
31. Bluth RF, Casey TT, McCurley TL. Differentiation of reactive from neoplastic small-cell lymphoid aggregates in paraffin-embedded marrow particle preparations using L-26 (CD20) and UCHL-1 (CD45RO) monoclonal antibodies. Am J Clin Pathol. 1993;99:150-156.
32. Maeda K, Hyun BH, Rebuck JW. Lymphoid follicles in bone marrow aspirates. Am J Clin Pathol. 1977;67:41-48.
33. Navone R, Valpreda M, Pich A. Lymphoid nodules and nodular lymphoid hyperplasia in bone marrow biopsies. Acta Haematol. 1985;74:19-22.
34. Rywlin AM, Ortega RS, Dominguez CJ. Lymphoid nodules of bone marrow: normal and abnormal. Blood. 1974;43:389-400.
35. Travis WD, Li CY, Yam LT, et al. Significance of systemic mast cell disease with associated hematologic disorders. Cancer. 1988;62:965-972.
36. Fromer JL, Jaffe N. Urticaria pigmentosa and acute lymphoblastic leukemia. Arch Dermatol. 1973;107:283-284.
37. Petrella T, Depret O, Arnould L, et al. Systemic mast cell disease associated with hairy cell leukaemia. Leuk Lymphoma. 1997;25:593-595.
38. Saletti P, Ghielmini M, Scali G, et al. Hodgkins and Castleman's disease in a patient with systemic mastocytosis. Ann Hematol. 1999;78:97-100.